The myotonic dystrophy type 2 (DM2) CCTG expansion does not prevent allele specific ZNF9 expression

被引：0
|
作者：
Malikowski, JM
Moseley, ML
Mosemiller, AK
Jin, D
Schoser, B
Kress, W
Ricker, K
Day, JW
Ranum, LPW
机构：
[1] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA
[2] Univ Munich, Munich, Germany
[3] Univ Wurzburg, Wurzburg, Germany
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2003年 / 73卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
2443
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [1] The myotonic dystrophy type 2 (DM2) CCTG expansion does not reduce ZNF9 transcript levels or prevent splicing.
    Ranum, LPW
    Moseley, ML
    Jin, DD
    Liquori, CL
    Day, JW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 502 - 502
  • [2] Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2)
    Botta, A
    Caldarola, S
    Vallo, L
    Bonifazi, E
    Fruci, D
    Gullotta, F
    Massa, R
    Novelli, G
    Loreni, F
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2006, 1762 (03): : 329 - 334
  • [3] Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9
    Liquori, CL
    Ricker, K
    Moseley, ML
    Jacobsen, JF
    Kress, W
    Naylor, SL
    Day, JW
    Ranum, LPW
    [J]. SCIENCE, 2001, 293 (5531) : 864 - 867
  • [4] Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2
    Raheem, Olayinka
    Olufemi, Shodimu Emmanuel
    Bachinski, Linda L.
    Vihola, Anna
    Sirito, Mario
    Hampf, Jeanette Holmlund
    Haapasalo, Hannu
    Li, Yi Ping
    Udd, Bjarne
    Krahe, Ralf
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (06): : 3025 - 3036
  • [5] The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles
    Massa, R.
    Panico, M. B.
    Caldarola, S.
    Fusco, F. R.
    Sabatelli, P.
    Terracciano, C.
    Botta, A.
    Novelli, G.
    Bernardi, G.
    Loreni, F.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (04) : 275 - 284
  • [6] Myotonic dystrophy type 2 is caused by a CCTG expansion in intron 1 of ZNF9.
    Ranum, LPW
    Liquori, CL
    Moseley, ML
    Jacobsen, JF
    Phillips, AV
    Savkur, R
    Kress, W
    Naylor, SL
    Cooper, TA
    Ricker, K
    Day, JW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 211 - 211
  • [7] Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population
    Vallo, L
    Bonifazi, E
    Borgiani, P
    Novelli, G
    Botta, A
    [J]. MOLECULAR AND CELLULAR PROBES, 2005, 19 (01) : 71 - 74
  • [8] Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy
    Cardani, R
    Mancinelli, E
    Sansone, V
    Rotondo, G
    Meola, G
    [J]. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2004, 48 (04): : 437 - 442
  • [9] Subcellular localization of the myotonic dystrophy type 2 protein ZNF9 in skeletal muscle
    Massa, R
    Panico, MB
    Fusco, FR
    Loreni, F
    Bernardi, G
    [J]. NEUROMUSCULAR DISORDERS, 2002, 12 (7-8) : 726 - 726
  • [10] New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2)
    Sallinen, R
    Vihola, A
    Bachinski, LL
    Huoponen, K
    Haapasalo, H
    Hackman, P
    Zhang, S
    Sirito, M
    Kalimo, H
    Meola, G
    Horelli-Kuitunen, N
    Wessman, M
    Krahe, R
    Udd, B
    [J]. NEUROMUSCULAR DISORDERS, 2004, 14 (04) : 274 - 283
12345